Get started
Author

Tamara Y. Alhobayb

Clostridium difficile in inflammatory bowel disease
2023 · Tamara Alhobayb, Matthew A. Ciorba · Current Opinion in Gastroenterology · 23
PDF
The Relationship between Acute and Chronic Pancreatitis with Pancreatic Adenocarcinoma: Review
2021 · Tamara Alhobayb, Rahul Peravali, et al. · Diseases · 20
PDF
COVID-19 infection triggering Thrombotic Thrombocytopenic Purpura
2021 · Mohammad Alhomoud, Tamara Alhobayb, et al. · IDCases · 16
Fr070 ANTI-CD20 MONOCLONAL ANTIBODIES ASSOCIATED COLITIS: ANALYSIS OF THE FOOD AND DRUG ADMINISTRATION ADVERSE EVENT REPORTING SYSTEM (FAERS)
2021 · Tamara Y. Alhobayb, Sarah A. Alharfi, et al. · Gastroenterology · 4
S2672 Influenza a Virus as a Trigger for Autoimmune Hepatitis
2020 · Tamara Alhobayb, Mayada Ismail, et al. · The American Journal of Gastroenterology · 1
Su1275 CAPSULE ENDOSCOPY IN OBSCURE GASTROINTESTINAL BLEEDING: DIAGNOSTIC YIELD IN THE INPATIENT VERSUS OUTPATIENT SETTING
2018 · Megan E. Reinders, Abdalla Khouqeer, et al. · Gastrointestinal Endoscopy · 1
PDF
Su1677 BASELINE PREDICTORS AND CLINICAL OUTCOMES OF RISANKIZUMAB DOSE OPTIMIZATION: A REAL-WORLD MULTICENTER RETROSPECTIVE STUDY
2026 · Amanda M. Johnson, Prajith R. Ramesh, et al. · Gastroenterology
Tu1652 REAL WORLD DURABILITY OF RESPONSE AND REMISSION AND PREDICTIORS AND OUTCOMES OF DOSE RE-ESCALATION OF UPADACITINIB IN PATIENTS WITH ULCERATIVE COLITIS: A MULTICENTER STUDY
2026 · Katherine Huang, Arun Chandnani, et al. · Gastrointestinal Endoscopy
Tu1652 REAL WORLD DURABILITY OF RESPONSE AND REMISSION AND PREDICTIORS AND OUTCOMES OF DOSE RE-ESCALATION OF UPADACITINIB IN PATIENTS WITH ULCERATIVE COLITIS: A MULTICENTER STUDY
2026 · Katherine Huang, Arun Chandnani, et al. · Gastroenterology
Su1677 BASELINE PREDICTORS AND CLINICAL OUTCOMES OF RISANKIZUMAB DOSE OPTIMIZATION: A REAL-WORLD MULTICENTER RETROSPECTIVE STUDY
2026 · Amanda M. Johnson, Prajith R. Ramesh, et al. · Gastrointestinal Endoscopy
Real World Durability of Response and Remission With Upadacitinib in Ulcerative Colitis: a Multicenter Study
2026 · Katherine Huang, Arun Chandnani, et al. · Inflammatory Bowel Diseases
PDF
Real World Durability of Response and Remission With Upadacitinib in Ulcerative Colitis: a Multicenter Study
2026 · Katherine Huang, Arun Chandnani, et al. · Gastroenterology
P0577 real world durability of response and remission with upadacitinib in Ulcerative Colitis: a multi-centre study
2026 · K Huang, A Chandnani, et al. · Journal of Crohn s and Colitis
DOP085 Baseline predictors and clinical outcomes of risankizumab dose optimization: a real-world multicenter retrospective study
2026 · A Johnson, P R Ramesh, et al. · Journal of Crohn s and Colitis
PDF
Tu1832: REAL-WORLD SAFETY OF UPADACITINIB IN ULCERATIVE COLITIS IN PATIENTS 50 YEARS OR OLDER: A MULTI-CENTER STUDY
2025 · Arun Chandnani, Katherine Huang, et al. · Gastroenterology
Gastrointestinal Histoplasmosis: Unveiling the Colon Cancer Facade in Crohn's Disease
2024 · Malek Ayoub, Mohammad Alharfi, et al. · Research Square
PDF
Endoscopic Hemostatic Powder Application in the Management of Acute Variceal Bleeding: a Systemic Review and Meta-analysis
2022 · Lolwa Al Obaid, Tamara Y. Alhobayb, et al. · Gastrointestinal Endoscopy
Tu1742 THE PREVALENCE OF DIEULAFOY LESIONS IN PATIENTS WITH CIRRHOSIS: A NATIONAL, POPULATION-BASED STUDY.
2020 · Tamara Y. Alhobayb, Mohammed Z. Sheriff, et al. · Gastroenterology
Sa1637 - Colonic Adenoma Risk in HIV Patients: A Case Control Study
2018 · Tamara Y. Alhobayb, Abdalla Khouqeer, et al. · Gastroenterology
Works count: 19
Citation count: 65
H-index: 4
I10-index: 3
Year
Topic
Type